Benzinga·2025-11-17 16:39Company Highlights - Jazz Pharmaceuticals PLC shares rose 18% to $166.56 after announcing positive top-line results from the Phase 3 HERIZON-GEA-01 trial for Ziihera in combination with chemotherapy for HER2-positive gastroesophageal adenocarcinoma [2] - PACS Group, Inc. shares jumped 49.5% to $15.82 ahead of its third-quarter results release on November 19 [5] - Sigma Lithium Corporation gained 30.5% to $7.91 following bullish FY26 demand guidance from Ganfgeng Lithium Group's chairman [5] - Zymeworks Inc. shares rose 29.5% to $24.00 due to significant improvements reported in the HERIZON-GEA-01 study [5] - Nuvalent Inc surged 16.5% to $112.44 after announcing positive pivotal data from the ALKOVE-1 clinical trial [5] - Vita Coco Company Inc shares jumped 9.1% to $47.84 after an upgrade from B of A Securities from Neutral to Buy, with a price target increase from $48 to $54 [5] Market Overview - U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday [1]